secwatch.observer — SEC 8-K summary
======================================

Issuer:     iRhythm Holdings, Inc. (IRTC)
CIK:        0001388658
Form:       8-K
Filed at:   2024-01-08T23:59:59+00:00
Accession:  0001388658-24-000006
Event type: other_material
Sentiment:  positive
Materiality: 0.80
Item codes: 1.01, 1.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

iRhythm closes $150M Braidwell loan, Q4 registrations +22%, guides FY2024 rev ~$580M
--------------------------------------------------------------------------------

- Closed $150M Braidwell term loan (initial $75M funded, $75M delayed draw), interest margin 6.5-6.95%, matures Jan 2029, replaces SVB facility.
- Preliminary Q4 2023 patient registrations grew >22% YoY.
- Full year 2024 revenue guidance $575-585M, representing ~18-20% growth vs 2023 midpoint.
- Submitted 510(k) for Zio AT system changes; received CE mark under EU MDR for Zio Monitor and ZEUS.
- CAMELOT study in American Heart Journal shows higher clinical diagnostic yield and lower retesting odds with Zio LTCM.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1388658/000138865824000006/0001388658-24-000006-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1388658/000138865824000006/irtc-20240103.htm
  HTML page:      https://secwatch.observer/filing/0001388658-24-000006

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer